Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
European Journal of Pharmacology
|
November 27, 2002
Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys
Blaire L Osborn, Les Sekut, Marta Corcoran, et al.
Neurobiology of Disease
|
June 4, 2017
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination
Ariana P Mullin, Charlene Cui, Yu Wang, et al.
Toxicology and Applied Pharmacology
|
August 7, 2017
Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure
Zhihong Huang, Douglas B Sawyer, Erika L Troy, et al.
Neuropharmacology
|
August 10, 2010
Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke
Jennifer F Iaci, Anindita Ganguly, Seth P Finklestein, et al.
Stroke
|
May 9, 2013
Dalfampridine improves sensorimotor function in rats with chronic deficits after middle cerebral artery occlusion
Jennifer F Iaci, Tom J Parry, Zhihong Huang, et al.
AAPS Pharmsci
|
July 10, 2002
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans
Cynthia Sung, Tom J Parry, Todd A Riccobene, et al.
Journal of Neurotrauma
|
August 10, 2016
AC105 Increases Extracellular Magnesium Delivery and Reduces Excitotoxic Glutamate Exposure within Injured Spinal Cords in Rats
Zhihong Huang, Zoran Filipovic, Nandakumar Mp, et al.
Experimental Neurology
|
November 10, 2023
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Mary Kate R Dwyer, Nicolas Amelinez-Robles, Isabella Polsfuss, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 26, 2017
Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa)
Merrie Mosedale, Donald Button, Jonathan P Jackson, et al.
European Journal of Pharmacology
|
July 5, 2008
Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist
Joseph W Gunnet, Pamela Wines, Min Xiang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
European Journal of Pharmacology
|
November 27, 2002
Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys
Blaire L Osborn, Les Sekut, Marta Corcoran, et al.
Neurobiology of Disease
|
June 4, 2017
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination
Ariana P Mullin, Charlene Cui, Yu Wang, et al.
Toxicology and Applied Pharmacology
|
August 7, 2017
Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure
Zhihong Huang, Douglas B Sawyer, Erika L Troy, et al.
Neuropharmacology
|
August 10, 2010
Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke
Jennifer F Iaci, Anindita Ganguly, Seth P Finklestein, et al.
Stroke
|
May 9, 2013
Dalfampridine improves sensorimotor function in rats with chronic deficits after middle cerebral artery occlusion
Jennifer F Iaci, Tom J Parry, Zhihong Huang, et al.
AAPS Pharmsci
|
July 10, 2002
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans
Cynthia Sung, Tom J Parry, Todd A Riccobene, et al.
Journal of Neurotrauma
|
August 10, 2016
AC105 Increases Extracellular Magnesium Delivery and Reduces Excitotoxic Glutamate Exposure within Injured Spinal Cords in Rats
Zhihong Huang, Zoran Filipovic, Nandakumar Mp, et al.
Experimental Neurology
|
November 10, 2023
NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury
Mary Kate R Dwyer, Nicolas Amelinez-Robles, Isabella Polsfuss, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 26, 2017
Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa)
Merrie Mosedale, Donald Button, Jonathan P Jackson, et al.
European Journal of Pharmacology
|
July 5, 2008
Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist
Joseph W Gunnet, Pamela Wines, Min Xiang, et al.
Page
of 3